Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05721287 · ClinicalTrials.gov registry record · Phase 1
A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults
A Phase 1 study of Pain and Acute Pain, sponsored by Sparian Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT05721287 is a Phase 1 study of Pain and Acute Pain that has completed, run by Sparian Biosciences. The registered enrollment target is 48 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05721287, a Phase 1 study of Pain and Acute Pain, has completed, sponsored by Sparian Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a single-center, double-blind, randomized placebo-controlled, adaptive, single ascending dose study.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG SBS-1000
Study Locations (1)
Kansas
- Altasciences Clinical Kansas - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-01-30 |
| Est. Completion | 2023-08-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05721287
The ClinicalTrials.gov registry entry for NCT05721287 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The listed sponsor is Sparian Biosciences, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05721287 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT05721287 about?
NCT05721287 is a clinical study titled "A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults". This study will be a single-center, double-blind, randomized placebo-controlled, adaptive, single ascending dose study.
What is the current status of trial NCT05721287?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2023-01-30. Estimated completion is 2023-08-30.
What conditions does trial NCT05721287 study?
This clinical trial studies the following conditions: Pain, Acute Pain.
What interventions are being tested in trial NCT05721287?
The interventions under investigation include: Placebo (DRUG), SBS-1000 (DRUG).
Who is sponsoring clinical trial NCT05721287?
This trial is sponsored by Sparian Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05721287 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.